The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer.

IF 1.6 4区 生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Iranian Journal of Biotechnology Pub Date : 2022-04-01 DOI:10.30498/ijb.2022.294933.3094
Fatemeh Khatami, Zahra Sadat Aghamir, Fatemeh Jahanshahi, Seyed Ariana Feiz-Abadi, Fatemeh Birang, Mahdi Khoshchehreh, Alireza Namazi Shabestari, Seyed Mohammad Kazem Aghamir
{"title":"The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer.","authors":"Fatemeh Khatami,&nbsp;Zahra Sadat Aghamir,&nbsp;Fatemeh Jahanshahi,&nbsp;Seyed Ariana Feiz-Abadi,&nbsp;Fatemeh Birang,&nbsp;Mahdi Khoshchehreh,&nbsp;Alireza Namazi Shabestari,&nbsp;Seyed Mohammad Kazem Aghamir","doi":"10.30498/ijb.2022.294933.3094","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The immune system is directly linked to the tumors, from tumor formation to the tumor's development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer treatment.</p><p><strong>Evidence acquisition: </strong>Genetic engineering and cellular immunotherapy are two different advanced molecular mechanisms to modify the immune responses and genome. Gene manipulation is the bioengineering technology that allows vectors to transfer new genetic information into the target cells. Cellular immunotherapy is an excellent strategy that connects the body's immune system to fight cancer.</p><p><strong>Results & conclusions: </strong>This review described that combination of genetic engineering and cellular immunotherapy has brought the novel antitumor repressive molecules stopping the tumor tissue immune tolerance and significantly expanding cancer therapy's effectiveness. Usually, cell immunotherapy and genetic engineering are considered two independent processes, and, in this review, we believe them in combinations. Here, we review these two novel approaches, and they are both combinations in terms of technological advances and clinical experience.</p>","PeriodicalId":14492,"journal":{"name":"Iranian Journal of Biotechnology","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d0/29/IJB-20-e3090.PMC9583824.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.30498/ijb.2022.294933.3094","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Context: The immune system is directly linked to the tumors, from tumor formation to the tumor's development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer treatment.

Evidence acquisition: Genetic engineering and cellular immunotherapy are two different advanced molecular mechanisms to modify the immune responses and genome. Gene manipulation is the bioengineering technology that allows vectors to transfer new genetic information into the target cells. Cellular immunotherapy is an excellent strategy that connects the body's immune system to fight cancer.

Results & conclusions: This review described that combination of genetic engineering and cellular immunotherapy has brought the novel antitumor repressive molecules stopping the tumor tissue immune tolerance and significantly expanding cancer therapy's effectiveness. Usually, cell immunotherapy and genetic engineering are considered two independent processes, and, in this review, we believe them in combinations. Here, we review these two novel approaches, and they are both combinations in terms of technological advances and clinical experience.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基因操作与细胞免疫治疗联合治疗肿瘤。
背景:免疫系统与肿瘤直接相关,从肿瘤的形成到肿瘤的发展和转移。因此,科学家们对保护性免疫机制的兴趣日益增加,并在癌症治疗中显示出天才的策略。证据获取:基因工程和细胞免疫治疗是改变免疫反应和基因组的两种不同的高级分子机制。基因操作是一种生物工程技术,它允许载体将新的遗传信息转移到目标细胞中。细胞免疫疗法是一种极好的策略,可以连接身体的免疫系统来对抗癌症。结果与结论:本文综述了基因工程与细胞免疫治疗的结合,带来了新的抗肿瘤抑制分子,阻断了肿瘤组织的免疫耐受,显著扩大了肿瘤治疗的有效性。通常,细胞免疫治疗和基因工程被认为是两个独立的过程,在本综述中,我们认为它们是联合的。在这里,我们回顾了这两种新颖的方法,它们都是技术进步和临床经验的结合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Iranian Journal of Biotechnology
Iranian Journal of Biotechnology BIOTECHNOLOGY & APPLIED MICROBIOLOGY-
CiteScore
2.60
自引率
7.70%
发文量
20
期刊介绍: Iranian Journal of Biotechnology (IJB) is published quarterly by the National Institute of Genetic Engineering and Biotechnology. IJB publishes original scientific research papers in the broad area of Biotechnology such as, Agriculture, Animal and Marine Sciences, Basic Sciences, Bioinformatics, Biosafety and Bioethics, Environment, Industry and Mining and Medical Sciences.
期刊最新文献
In-Silico Method for Predicting Pathogenic Missense Variants Using Online Tools: AURKA Gene as a Model. A Meta-analysis of Transcriptome Data to Investigate the Effect of Soy Isoflavones on Breast Cancer Cell. DNA Methyltransferase Inhibition by RG108 Improves Stemness and Multipotential Differentiation of Human Adipose Tissue-derived Stem Cells. Docking-Based Virtual Screening Method for Selecting Natural Compounds with Synergistic Inhibitory Effects Against Cancer Signalling Pathways Using a Multi-Target Approach. Increased Expression Level of Human Blood Clotting Factor VIII Using NS0 Cell Line as a Host Cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1